The stock market contains many companies trying to fight the world’s biggest diseases. While investors have plenty of options to back potentially life-saving businesses, can you actually make any money from these types of high-risk investments? Read the new issue of Shares to find out.
Also this week: How to earn £10,000 a year from your investments; three ways to smooth investment returns; and a comparison of two multi-manager investment trusts: Alliance Trust versus Witan.
You can learn about a £1.66bn chemicals company in hot demand; discover the bull and bear case for Morrisons; and read a debate on whether the stock market is over-reacting to bad news.
Also this week: How to earn £10,000 a year from your investments; three ways to smooth investment returns; and a comparison of two multi-manager investment trusts: Alliance Trust versus Witan.
You can learn about a £1.66bn chemicals company in hot demand; discover the bull and bear case for Morrisons; and read a debate on whether the stock market is over-reacting to bad news.
Editor's View
Feature
Story In Numbers
-
Cobalt price rally ‘could last for another two years’
New forecasts imply significant price appreciation in both 2018 and 2019 -
Further value wiped off toilet roll provider Accrol
Small cap disappoints the market yet again with terrible trading update -
Eurozone inflation revised down
Reading reinforces expectations for gradual exit from quantitative easing programme
Great Ideas
Great Ideas Update
Great Ideas Update
Investment Trusts
Great Ideas Update
Money Matters
Week Ahead
-
Next gets set to deliver
Best-in-class retailer to update on current sales trends and consumer economy outlook -
High expectations at Taptica ahead of full year results
Israeli ad tech firm set to report numbers on 26 March -
Has CMC weathered the storm?
Regulatory chances and the use of leverage raised serious concerns at the end of 2017
Money Matters
News
Money Matters
News
Sign up to our
daily email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
